James C. Foster, a director at Charles River Laboratories International, Inc., has reported significant stock transactions in a recent SEC filing. This activity, filed on October 26, 2026, includes both the acquisition and sale of common stock, reflecting Foster's active management of his holdings.
The filing details that on October 22, 2026, Foster acquired 24,042 shares of common stock at a price of $244.41 per share. Additionally, he sold the same number of shares at a higher price of $350.00 per share, resulting in a notable transaction that may suggest confidence in the company's performance.
Foster's transactions are part of a broader trend in the commercial physical and biological research industry, where insider trading activity can provide insights into the confidence levels of company executives. The SEC filing highlights that Foster now holds a total of 55,638 shares following these transactions.
Charles River Laboratories, headquartered in Wilmington, Massachusetts, is a prominent player in the commercial physical and biological research sector. The company is known for its comprehensive services that support the pharmaceutical and biotechnology industries.
The SEC filing, accession number 0001100682-26-000153, outlines the specifics of Foster's transactions. It indicates that the acquisition was classified under the transaction code 'M' for acquisition, while the sale was marked as 'S' for disposition. Both transactions occurred on the same day, showcasing a strategic approach to stock management.
Foster's current holdings include various trusts, with significant shares held indirectly. For instance, he has 20,000 shares in a trust for 2026 and additional holdings in trusts for 2024 and 2025. This diversified ownership structure may reflect his long-term investment strategy.
As a director, Foster's actions may influence investor sentiment and market perception of Charles River Laboratories. Insider trading, especially when conducted transparently, can be a positive signal to investors regarding a company's prospects.
Looking ahead, the filing does not specify any upcoming actions or further disclosures related to Foster's holdings. However, continued monitoring of insider transactions could provide valuable insights into the company's future direction.
Overall, Foster's recent transactions underscore the dynamic nature of insider trading within the industry, highlighting the importance of transparency and strategic decision-making in maintaining investor confidence.